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Abstract
Introduction—Although magnesium plays an important role in aerobic metabolism and 
magnesium deficiency is a common phenomenon in critical illness, the association between 
magnesium deficiency and lactic acidosis in the intensive care unit (ICU) has not been defined.
Methods—This was a retrospective, cross-sectional study conducted at a 77 ICU bed tertiary 
medical center. Data pertaining to the first unique admission of any ICU patient between 2001 and 
2008 were extracted from the Multiparameter Intelligent Monitoring in Intensive Care database. 
Hypomagnesemia was defined as serum magnesium <1.6 mg/dL. Mild and severe lactic acidosis 
were defined as lactate concentrations of >2 and > 4 mmol/L, respectively. Multivariate modeling 
was used to explore the association between magnesium and lactate concentrations.
Results—Of 8922 critically ill patients, 22.6% were hypomagnesemic. Hypomagnesemia was 
associated with an increased adjusted risk of mild lactic acidosis (odds ratio [OR] 1.71, 95% 
confidence interval [95%CI] 1.51–1.94, P < .001) and severe lactic acidosis (OR 1.56, 95%CI 
1.32–1.84, P < .001) than the reference quartile. The association between hypomagnesemia and 
mild lactic acidosis was stronger in those at risk of magnesium deficiency, including diabetics (OR 
2.02, 95%CI 1.51–2.72, P < .001) and alcoholics (OR 1.92, 95%CI 1.16–3.19, P = .01). As an 
internal model control, hypokalemia was not associated with an increased risk of lactic acidosis.
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Conclusions—Magnesium deficiency is a common finding in patients admitted to the ICU and 
is associated with lactic acidosis. Our findings support the biologic role of magnesium in 
metabolism and raise the possibility that hypomagnesemia is a correctable risk factor for lactic 
acidosis in critical illness.
Keywords
magnesium deficiency; acidosis; lactic; critical illness; oxidative phosphorylation; nutritional 
deficiency
Introduction
Magnesium is an abundant intracellular cation that contributes to a range of physiologic 
processes including energy storage and utilization, protein metabolism, inflammation, and 
electrolyte homeostasis.1,2 Hypomagnesemia is a common laboratory finding in the 
intensive care unit (ICU) setting with an estimated prevalence between 20% and 65%.3,4 
Among the total population of critically ill patients, those with alcoholism and diabetes have 
the highest rates of magnesium deficiency, presumably due to a combination of intracellular 
and extracellular magnesium depletion.4,5 In the ICU, magnesium deficiency has been 
associated with worse outcomes including longer length of stay and increased mortality.6–8
Magnesium plays an important role in oxidative metabolism. The conversion of thiamine to 
its active triphosphate form is reliant on magnesium as a cofactor.9–11 Thiamine 
pyrophosphate, in conjunction with pyruvate dehydrogenase, is critical in the metabolism of 
pyruvate to acetyl coenzyme A for entrance into the citric acid cycle.12 In the absence of 
magnesium, disrupted oxidative phosphorylation shifts toward anaerobic metabolism, 
resulting in lactic acid production. Magnesium infusion attenuates lactate production during 
surgical procedures13 and intense physical exercise,14 but little information exists on the 
association of magnesium and lactate concentrations in the critically ill patients.
Given the prevalence of magnesium deficiency in critical illness and the morbidity 
associated with lactic acidosis, we investigated whether lower magnesium concentrations are 
associated with lactic acidosis in critically ill patients. We further hypothesized that the 
association between magnesium and lactate concentrations would be stronger in those at risk 
of intracellular magnesium deficiency and performed subgroup analyses in those with a 
history of diabetes and chronic alcoholism. In addition, we assessed whether the unbound 
fraction of extracellular magnesium was associated with lactic acidosis. Finally, we 
evaluated the association of magnesium concentrations in patients admitted with sepsis.
Materials and Methods
Study Population
The study population was drawn from the Multiparameter Intelligent Monitoring in 
Intensive Care II (MIMIC-II) research database, a joint venture managed by researchers 
from the Laboratory of Computational Physiology at Massachusetts Institute of Technology 
(MIT) and Beth Israel Deaconess Medical Center (BIDMC). The MIMIC-II contains data 
from 24 581 adult patients who were admitted to surgical or medical ICUs at BIDMC. The 
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database contains high temporal resolution data from clinical systems, including laboratory 
results, electronic documentation, and bedside monitor trends and waveforms, for patients 
admitted to a BIDMC ICU between 2001 and 2008.15 Use of the MIMIC-II database has 
been approved by the institutional review boards of BIDMC and the MIT.
Of 11 129 patients with a recorded admission lactate concentration, 9681 also had a serum 
magnesium concentration. Patients were excluded if they were missing admission Simplified 
Acute Physiology Scores (SAPSs; n = 640), creatinine level (n = 48), or demographic 
information (n = 81), leaving 8922 unique first admissions. All laboratory data were 
determined by selecting the first measured value starting from 12 hours prior to ICU 
admission and extending until 12 hours after ICU admission.
Outcome
The primary end point was lactic acidosis, defined as an admission serum lactate 
concentration >2 mmol/L in keeping with our hospital’s laboratory normal range. Given that 
higher concentrations of lactic acid are more predictive of outcome in the critically ill 
patients, we also defined severe lactic acidosis as a concentration >4 mmol/L.16
Exposure
The primary exposure was admission magnesium concentration, assessed as quartiles and 
continuously. Hypomagnesemia was defined as a serum magnesium concentration <1.6 
mg/dL, in keeping with our hospital laboratory’s definition, which was also the lowest 
quartile. To estimate the amount of unbound extracellular magnesium, corrected magnesium 
concentrations were determined using a previously defined formula: Corrected Magnesium 
= Serum magnesium + 0.005 × (40 − Serum albumin).17 Magnesium concentrations were 
winsorized at the 0.5th and 99.5th percentiles to limit the effect of outliers.
Statistical Analysis
We report baseline patient characteristics and laboratory data by quartiles. Sequential, 
multivariate models were created to define the association between magnesium 
concentrations, assessed as quartiles and as a continuous variable. For all analyses of cohort 
quartiles, the third magnesium quartile was used as reference. This reference value was 
chosen as it most closely reflects normal magnesium concentrations. Age, admission systolic 
blood pressure, admission SAPS, and admission serum creatinine were defined as 
continuous variables. Race and admission service type (medical, cardiac, surgical, or 
cardiothoracic ICU) were coded categorically. Oliguria was defined as a urine output less 
than 400 mL during the first 24 hours of ICU care.18 We included all 30 Elixhauser 
comorbidities as individual variables rather than a summary score.19 Model I presents the 
unadjusted association. Model II adds age, gender, ethnicity, and SAPS. Given the marked 
effect of renal function on magnesium concentrations, we included both SAPS and serum 
creatinine, along with Elixhauser comorbidities, ICU type, and blood pressure in model III. 
Separate regressions for lactic acidosis (>2 mmol/L) and severe lactic acidosis (>4 mmol/L) 
were performed.
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In subgroup analyses, the International Classification of Diseases, Ninth Revision were used 
to identify patients with a history of chronic alcoholism or diabetes. A multiplicative 
interaction between serum magnesium and a binary term for either diabetes or chronic 
alcoholism, versus none, was tested (P = .03), and further stratification was performed. 
Magnesium was examined in quartiles and continuously. A subgroup analysis of patients 
who were admitted to the ICU with sepsis was performed. Patients with sepsis were 
identified using the Martin criteria.20 To better estimate unbound magnesium concentrations, 
a sensitivity analysis was performed using the corrected magnesium concentration.
As potassium is a primarily intracellular cation similarly affected by the balance of 
nutritional intake and renal excretion,21,22 we tested the relationship between hypokalemia 
and lactic acidosis as a secondary outcome to ensure the specificity of observed associations. 
All statistical analyses were performed using JMP Pro, a component of SAS (Cary, North 
Carolina).
Results
Baseline Characteristics
The cohort mean magnesium concentration was 1.9 (±0.54) mg/dL. In all, 22.6% of the 
cohort was hypomagnesemic, who tended to be younger, with a higher prevalence of 
alcoholism and diabetes, and with better renal function, than those with elevated magnesium 
concentrations (Table 1).
Association of Magnesium Concentration and Mild Lactic Acidosis
Overall, 4362 (48.9%) patients exhibited mild lactic acidosis with 58.6%, 49.5%, 43.4%, 
and 46.5% in the lowest to highest magnesium quartile, respectively. In unadjusted analysis 
(Table 2), the lowest magnesium quartile had an 85% increased odds of mild lactic acidosis 
(odds ratio [OR] 1.85, 95% confidence interval [95%CI] 1.64–2.08, P < .001) compared to 
patients in the reference quartile. This relationship remained highly significant after 
adjustment (OR 1.71, 95%CI 1.51–1.94, P value <.001). Patients in the second magnesium 
quartile were also more likely to have lactic acidosis (OR 1.29, 95%CI 1.13–1.47, P < .001) 
in adjusted analysis. Each 1 mg/dL increase in magnesium concentration was associated 
with a 25% lower odds of lactic acidosis when evaluated continuously (OR 0.75, 95%CI 
0.67–0.83, P < .001).
Association of Magnesium Concentration and Severe Lactic Acidosis
Lactate levels were >4 mmol/L in 17.6% of patients in our cohort. In all, 23.0%, 16.5%, 
14.8%, and 17.0% in the lowest to highest magnesium quartile, respectively, had severe 
lactic acidosis. Patients with hypomagnesemia were 72% more likely to have severe lactic 
acidosis (OR 1.72, 95%CI 1.48–2.00, P < .001) when compared to the reference category 
(Table 3). This remained significant in adjusted analysis (OR 1.56, 95%CI 1.32–1.84, P < .
001). Each 1 mg/dL increase in magnesium concentration was associated with a 21% lower 
odds of severe lactic acidosis when evaluated continuously (OR 0.79, 95%CI 0.69–0.91, P 
< .001).
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Association of Magnesium Concentration and Lactic Acidosis in Alcoholics and Diabetics
Of the 2022 (22.7%) patients with a history of diabetes, 17.6% were hypomagnesemic, 
which was associated with a 2-fold increased risk of mild lactic acidosis (OR 2.02, 95%CI 
1.51–2.72, P < .001), as seen in Table 4. Patients with diabetes and magnesium deficiency 
likewise had increased odds of severe lactic acidosis, although this did not reach statistical 
significance (OR 1.34, 95%CI 0.92–1.96). Of the 626 (7.0%) patients with a history of 
chronic alcohol use, 28.6% were hypomagnesemic, which was associated with 92% 
increased odds of mild lactic acidosis (OR 1.92, 95%CI 1.16–3.19, P = .01) and a 2-fold 
increase in severe lactic acidosis (OR 2.09, 95%CI 1.11–4.00).
Association of Corrected Magnesium Concentrations and Lactic Acidosis
Admission albumin measurements were available in 3897 (43.7%) patients in the cohort. 
The mean (standard deviation) magnesium and corrected magnesium concentrations in this 
subgroup were 1.91 (±0.46) and 1.96 (±0.45) mg/dL, respectively. In adjusted analysis, a 
corrected magnesium <1.6 mg/dL was associated with an 80% increased risk of mild lactic 
acidosis (OR 1.80, 95%CI 1.47–2.19, P < .001).
Association of Magnesium Concentration and Lactic Acidosis in Sepsis
There were 1765 patients admitted with sepsis. The mean lactate concentration was 2.76 
mmol/L (±2.33). Hypomagnesemia in sepsis was associated with a 2-fold increased risk of 
lactic acidosis (OR 2.03, 95%CI 1.50–2.76, P < .001) when compared to the reference 
quartile. Patients in the second and fourth magnesium quartiles also had increased rates of 
lactic acidosis when compared to reference category.
Association of Hypokalemia and Lactic Acidosis
Hypokalemia was present in 614 (7.1%) patients in the cohort. In adjusted analysis, 
hypokalemia was not significantly associated with lactic acidosis (OR 1.05, 95%CI 0.89–
1.26, P = .55).
Discussion
In this large, single-center analysis of critically ill patients, lower magnesium concentrations 
were associated with an increased risk of mild and severe lactic acidosis. The effect of 
magnesium on the risk of lactate acidosis was greater in those predisposed to intracellular 
and extracellular magnesium depletion.
Our findings extend an awareness of magnesium deficiency as a risk factor for anaerobic 
metabolism and lactate production, well described with the metabolic stress of intense 
physical exercise, to the metabolic stress of critical illness.14 In adjusted analyses, including 
measurement of comorbidities, illness severity, blood pressure, and renal function, 
hypomagnesemia remained a significant predictor of lactic acidosis. Although lactic acidosis 
in critical illness is often assumed to reflect tissue hypoperfusion in response to a low-flow 
state and used to direct fluid resuscitation strategies, our analyses suggest that magnesium 
concentrations are an additional independent predictor.
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Because magnesium is predominantly intracellular, and because the remaining extracellular 
component is highly protein bound, serum measurement may not accurately reflect 
biologically available magnesium.23–25 Since neither intracellular nor free magnesium 
measurements are routinely available,26,27 we studied patients known to be at risk of total 
body magnesium depletion, hypothesizing that the effect of serum magnesium on lactate 
production would be strengthened in those with both intracellular and extracellular 
magnesium depletion. Diabetics are considered particularly prone to magnesium depletion 
due to a combination of lower dietary magnesium intake and increased renal excretion as 
well as an alteration in transcellular transport.28–30 Insulin deficiency may affect the Na+/H+ 
antiporter in the renal proximal tubule leading to magnesium wasting.31 Similarly, those 
with chronic alcoholism are at an increased risk of hypomagnesemia due to the diuretic 
action of alcohol coupled with decreased magnesium consumption.32 In our cohort, the 
association between magnesium deficiency and lactic acidosis was strengthened in patients 
with either diabetes or chronic alcoholism.
To determine whether “free” magnesium concentrations were associated with lactic acidosis, 
we used a correction factor to assess the amount of unbound extracellular magnesium. 
Corrected magnesium concentrations remained significant predictors of lactic acidosis.
In addition to its critical role in oxidative phosphorylation, magnesium deficiency has been 
shown to have important immunomodulatory effects.1 In a magnesium-deficient animal 
model, inflammatory cytokines including tumor necrosis factor α, interleukin 1, substance P, 
and calcitonin gene-related peptide were elevated.33,34 Further, hypomagnesemia may lead 
to impaired macrophage activation and leukocyte adherence to pathogens.35 In experimental 
sepsis, magnesium deficiency is associated with increased mortality and magnesium 
replacement is protective.36 In our analysis, patients with sepsis having hypomagnesemia 
had a more than 2-fold increased risk of lactic acidosis than the reference quartile. A 
combination of impaired glucose metabolism, coupled with a heightened inflammatory 
response, may account for the strong association between magnesium deficiency and lactic 
acidosis in those patients admitted with sepsis.
Our study has a number of limitations. The cross-sectional design prohibits conclusions 
about potential causality. In addition, our data set lacked the granularity to ascertain the 
time-lapse between magnesium and lactate measurements. Although we were able to 
calculate corrected magnesium, neither intracellular nor free magnesium concentrations 
were available. Information about dietary magnesium intake and over-the-counter dietary 
magnesium supplementations was not available. However, potassium, which is also largely 
dietary derived, was not associated with lactic acidosis when used as an internal model 
control, and the inclusion of albumin, a marker of general nutrition, did not attenuate the 
association between magnesium and lactic acidosis.
Conclusion
Magnesium deficiency is a common finding in critical illness and is associated with lactic 
acidosis. Whether this association is due to residual confounding will require further well-
designed interventional studies. Our findings support the biologic role of magnesium in 
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cellular metabolism and suggest that future studies should explore early magnesium 
repletion as a resuscitation goal.
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